893 related articles for article (PubMed ID: 20884297)
1. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
[TBL] [Abstract][Full Text] [Related]
2. Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.
Zanetti A; Parlato A; Romanò L; Desole MG; Ferrera G; Giurdanella F; Zuliani M; Richard P; Thomas S; Fiquet A
Vaccine; 2012 Aug; 30(39):5770-5. PubMed ID: 22789511
[TBL] [Abstract][Full Text] [Related]
3. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.
Zanetti A; Desole MG; Romanò L; d'Alessandro A; Conversano M; Ferrera G; Panico MG; Tomasi A; Zoppi G; Zuliani M; Thomas S; Soubeyrand B; Eymin C; Lockhart S
Vaccine; 2017 Jul; 35(32):4034-4040. PubMed ID: 28624307
[TBL] [Abstract][Full Text] [Related]
4. Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type B vaccines and evaluation of booster vaccination.
Tichmann I; Grunert D; Habash S; Preidel H; Schult R; Pfletschinger U; Gildberg PK; Meurice F; Sänger R
Hum Vaccin; 2006; 2(6):249-54. PubMed ID: 17106268
[TBL] [Abstract][Full Text] [Related]
5. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.
Giambi C; Bella A; Barale A; Montù D; Marchisio M; Oddone M; Zito S; Rapicetta M; Chionne P; Madonna E; Ciofi degli Atti ML
BMC Infect Dis; 2008 Jul; 8():100. PubMed ID: 18662386
[TBL] [Abstract][Full Text] [Related]
6. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
Dhillon S
BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
[TBL] [Abstract][Full Text] [Related]
8. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
Tregnaghi M; Zambrano B; Santos-Lima E
Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
[TBL] [Abstract][Full Text] [Related]
9. Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
Behre U; Van Der Meeren O; Crasta P; Hanssens L; Mesaros N
Hum Vaccin Immunother; 2016 Nov; 12(11):2916-2920. PubMed ID: 27653771
[TBL] [Abstract][Full Text] [Related]
10. Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
Schwarz TF; Behre U; Adelt T; Donner M; Suryakiran PV; Janssens W; Mesaros N; Panzer F
Hum Vaccin Immunother; 2019; 15(1):235-241. PubMed ID: 30118633
[TBL] [Abstract][Full Text] [Related]
11. DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.
Dhillon S
Drugs; 2010 May; 70(8):1021-58. PubMed ID: 20481658
[TBL] [Abstract][Full Text] [Related]
12. Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006.
Jorgensen P; Poethko-Müller C; Hellenbrand W; Jilg W; Thierfelder W; Meyer C; an der Heiden M; Schlaud M; Radun D
Epidemiol Infect; 2010 Nov; 138(11):1621-9. PubMed ID: 20233496
[TBL] [Abstract][Full Text] [Related]
13. Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months.
Kosalaraksa P; Chokephaibulkit K; Benjaponpitak S; Pancharoen C; Chuenkitmongkol S; B'Chir S; Da Costa X; Vidor E
Hum Vaccin Immunother; 2018 May; 14(5):1257-1265. PubMed ID: 29333947
[TBL] [Abstract][Full Text] [Related]
14. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
15. Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine.
Van Der Meeren O; Bleckmann G; Crasta PD
Hum Vaccin Immunother; 2014; 10(6):1682-7. PubMed ID: 24637296
[TBL] [Abstract][Full Text] [Related]
16. Loss of antibodies, but not of protection.
Wenzel JJ; Jilg W
Lancet Infect Dis; 2010 Nov; 10(11):738-9. PubMed ID: 21029981
[No Abstract] [Full Text] [Related]
17. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example.
Rosado MM; Scarsella M; Pandolfi E; Cascioli S; Giorda E; Chionne P; Madonne E; Gesualdo F; Romano M; Ausiello CM; Rapicetta M; Zanetti AR; Tozzi A; Carsetti R
Eur J Immunol; 2011 Jun; 41(6):1800-8. PubMed ID: 21469123
[TBL] [Abstract][Full Text] [Related]
18. Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine.
Zinke M; Kappes R; Kindler K; Paulus-Koschik A; Goering U; Disselhoff J; Soemantri P; Grunert D; Laakmann KH; Gunasekaran R; Gartner B; Jacquet JM
Hum Vaccin; 2009 Sep; 5(9):592-8. PubMed ID: 19535920
[TBL] [Abstract][Full Text] [Related]
19. Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.
Romanò L; Zanetti AR
J Prev Med Hyg; 2011 Jun; 52(2):45-6. PubMed ID: 21842704
[No Abstract] [Full Text] [Related]
20. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants.
Mallet E; Fabre P; Pines E; Salomon H; Staub T; Schödel F; Mendelman P; Hessel L; Chryssomalis G; Vidor E; Hoffenbach A;
Pediatr Infect Dis J; 2000 Dec; 19(12):1119-27. PubMed ID: 11144370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
